Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @adjcap
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @adjcap
-
Adjuvant Capital proslijedio/la je Tweet
Michael Chang of
@adjcap remarks that the antibiotics space lacks a procurement agency like@GAVI, but could benefit from subscription-like mechanisms for access.#AMRIncentivespic.twitter.com/3W2XcOcLvi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
@DukeMargolis is investigating population-based payments that create strong incentives for the development, availability, and appropriate use of priority antibiotics, and better reflect the#publichealth value effective antibiotics provide#AMRIncentives https://healthpolicy.duke.edu/sites/default/files/atoms/files/margolis_subscription_model_14jan2020.pdf …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
"Software is eating the way we make vaccines"


Kudos to @adjcap investees@Codagenix and@Themis_Bio for leveraging next-generation technologies to test new vaccination approaches.https://endpts.com/gates-vets-at-adjuvant-back-codagenixs-software-driven-approach-to-recoding-rsv-flu-oncolytic-viruses-and-more/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Adjuvant Capital proslijedio/la je Tweet
Sometimes sub-optimal = best???


When it comes to live attenuated vaccines and oncolytics, we certainly hope so, and @adjcap just placed a big bet on@Codagenix's codon de-optimization technology by leading their $20 million Series B.https://www.prnewswire.com/news-releases/codagenix-raises-20-million-in-series-b-funding-for-continued-development-of-rsv-influenza-and-oncolytic-virus-products-300985805.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
Thrilled to announce our investment in
@Codagenix to support the development of their computational + synthetic biology platform for "rational" vaccine design. Onward! https://www.prnewswire.com/news-releases/codagenix-raises-20-million-in-series-b-funding-for-continued-development-of-rsv-influenza-and-oncolytic-virus-products-300985805.html?tc=eml_cleartime …pic.twitter.com/dNz0boeVwuHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Announcing our investment in Codagenix, Inc. to support the rational design of vaccines for high burden infectious diseases!https://www.prnewswire.com/news-releases/codagenix-raises-20-million-in-series-b-funding-for-continued-development-of-rsv-influenza-and-oncolytic-virus-products-300985805.html?tc=eml_cleartime …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Announcing our investment in the formation of AN2 Therapeutics to tackle infectious diseases, including Melioidosis, a deadly neglected tropical disease endemic to SE Asia. https://adjuvantcapital.com/news/melioidosis-ever-heard-of-it/ …pic.twitter.com/rNwap2HzFw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
Latest issue of Field Notes from
@adjcap (w/@michael_c_chang) is out!https://link.medium.com/OAzYmfagn1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
Our sincerest thanks to
@EIB for the innovative financing provided to support@BiologicsforAll! ### "These diseases pose an increasing threat to humanity, yet the field remains under-invested. It will be a major war and the battle has just begun.” -EIB DG Jean-Christophe Lalouxhttps://twitter.com/EIB/status/1179747331899572224 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great to see some of our earliest supporters including
@BillGates,@melindagates, and@RayDalio featured in@Forbes!https://www.forbes.com/sites/forbeswealthteam/2019/10/02/impact-50-5-billion-and-more/#2d0f078a17d3 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
Check out the latest edition of Field Notes for a taste of what the
@adjcap team has been reading and discussing the last few weeks!https://medium.com/field-notes-by-adjuvant-capital/field-notes-v-85c73aff3901 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This week's Field Notes is live. Check out what the Adjuvant team is reading and discussing this week!https://medium.com/field-notes-by-adjuvant-capital/field-notes-v-85c73aff3901 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
Check out our latest Field Notes for a taste of what the
@adjcap team has been reading the last few weeks! https://medium.com/field-notes-by-adjuvant-capital/field-notes-v-85c73aff3901 …pic.twitter.com/2voApXQCiY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
What is the world's deadliest animal? It's not sharks, nor alligators or humans – it's mosquitoes. In our latest guest article, read how investors like
@adjcap are stepping up in the fight against mosquito-transmitted diseases#globalhealth#impinvhttp://ow.ly/gtit50wmvHYHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
“I wish I could say everyone has jumped on the bandwagon. For global health, it isn’t true.” - Jenny Yip, General Partner at Adjuvant Capital featured in
@barronsonline https://www.barrons.com/articles/financing-global-health-51569243601?mod=hp_LATEST …pic.twitter.com/Vpq04WrCrT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
Wow.
@aschultzpenta at@barronsonline absolutely nailed it
with her story about @gatesfoundation,@wellcometrust,@MedicinesDev,@adjcap,@theGHIF,@WHO and the work we are all doing to fund new technologies for major public health challenges. ### https://www.barrons.com/articles/financing-global-health-51569243601?mod=hp_LATEST …pic.twitter.com/aovu38977X
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
Excited to announce that
@adjcap participated in@Themis_Bio's Series D alongside Farallon Capital, Hadean Ventures and Merck to support the company’s Phase 3 study for its Chikungunya vaccine. Never heard of Chikungunya virus? Ask me about it!https://www.themisbio.com/themis-raises-eur-40-million-in-series-d-financing-round-backed-by-us-eu-consortium-to-support-pivotal-study-and-expand-clinical-pipeline/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thrilled to be joined by
@Merck, Farallon Capital, and Hadean Ventures, along with existing partners@Omnes_VC@Ventech_VC and@wellingtonvc, on the@Themis_Bio journey!https://twitter.com/endpts/status/1174289282430902272 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant Capital proslijedio/la je Tweet
In a move that should make sheep around the world rejoice
, we are pleased to share that @adjcap has committed $7m to help InDevR commercialize its multiplexed protein quantification technology and expand the menu of biologics that can be characterized. https://adjuvantcapital.com/news/bringing-biologic-potency-testing-into-the-21st-century/ …pic.twitter.com/bafZtJoX7c
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
